Profile
Stuart Kupfer is Senior Vice President-Clinical Development at Cytokinetics, Inc. since 2026.
Formerly, Dr. Kupfer was Vice President & Head-Therapeutic Area at Takeda Pharmaceuticals U.S.A., Inc. from 2004 to 2016.
Dr. Kupfer also worked at the University of Washington.
Dr. Kupfer earned a doctorate from the University of Florida.
Stuart Kupfer active positions
| Companies | Position | Start |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Chief Tech/Sci/R&D Officer | 2019-12-31 |
Former positions of Stuart Kupfer
| Companies | Position | End |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 2015-12-31 |
Training of Stuart Kupfer
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
Cytokinetics, Inc.
Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
- Stock Market
- Insiders
- Stuart Kupfer
















